清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Kidney Transplant Recipients with Post-transplant Diabetes Mellitus (PTDM)- a Systematic Review and Meta-Analysis

医学 磷酸西他列汀 内科学 糖尿病 2型糖尿病 他克莫司 血糖性 荟萃分析 临床终点 安慰剂 二肽基肽酶-4 移植 胃肠病学 随机对照试验 胰岛素 2型糖尿病 内分泌学 替代医学 病理
作者
Tarek Abdelaziz,Ahmed Yamany Ali,Moataz Fatthy
出处
期刊:Current Diabetes Reviews [Bentham Science Publishers]
卷期号:16 (6): 580-585 被引量:12
标识
DOI:10.2174/1573399815666190321144310
摘要

Background: Kidney transplant recipients may develop post-transplant diabetes mellitus (PTDM). Dipeptidyl peptidase 4(DPP-4) inhibitors are evolving agents in the management of patients with diabetes mellitus. Aims: To evaluate the efficacy and safety of DPP-4 inhibitors in the management of post-transplant diabetes mellitus (PTDM) in renal transplant recipients. Methods: We performed a systematic search of the electronic databases using keys words and Mesh terms. Data were extracted and reviewed using structured proforma. A comprehensive review of the eligible studies was performed independently by each of two reviewers; conflicts were resolved by the third reviewer. The primary efficacy endpoint was the difference in glycosylated hemoglobin (HbA1c) comparing any of the DPP-4 inhibitors to either placebo or other hypoglycaemic agent. The primary safety endpoints were the worsening of graft functions and change in Tacrolimus trough level. We performed the Random effect model using standardised mean difference. Results: We identified seven studies that were eligible for the systematic review; only one study compared Sitagliptin to insulin Glargine. One study involved head to head comparison of three DPP-4 inhibitors. The other five studies were pooled in the meta-analysis. DPP-4 inhibitors had a favourable glycemic effect as measured by HbA1c when compared to either placebo or oral anti-hyperglycemic medications (standardised mean difference in HbA1c = -0.993, 95% CI= -1.303 to -0.683, P=0.001). DPP-4 inhibitors use did not result in significant change in eGFR ((standardised mean difference = 0.147, 95% CI= -0.139 - 0.433, p=0.312).) nor Tacrolimus level (standardised Mean Difference= 0.152, 95% CI= -0.172 to 0.477, P=0.354). Conclusion: Current evidence supports the short term efficacy and safety of DDP-4 inhibitor agents in the management of post transplantation diabetes mellitus (PTDM) in kidney transplant recipients. However, more RCTs are required to investigate the long-term safety and efficacy of these agents in kidney transplant recipients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乔杰完成签到 ,获得积分10
19秒前
全球免费科研1完成签到 ,获得积分10
1分钟前
1分钟前
Sunny完成签到,获得积分10
2分钟前
研友_8Y26PL完成签到 ,获得积分10
2分钟前
赵勇完成签到 ,获得积分10
2分钟前
随心所欲完成签到 ,获得积分10
3分钟前
4分钟前
XX发布了新的文献求助10
4分钟前
Hello应助六亿采纳,获得10
4分钟前
实力不允许完成签到 ,获得积分10
5分钟前
hwen1998完成签到 ,获得积分10
5分钟前
5分钟前
六亿发布了新的文献求助10
5分钟前
尧桦完成签到 ,获得积分10
5分钟前
酷波er应助hqc采纳,获得10
6分钟前
6分钟前
24601发布了新的文献求助10
6分钟前
6分钟前
hqc发布了新的文献求助10
6分钟前
6分钟前
7分钟前
六亿完成签到,获得积分10
7分钟前
Simpson完成签到 ,获得积分10
7分钟前
Peckhin完成签到 ,获得积分10
7分钟前
我一进来就看到常威在打来福完成签到,获得积分10
7分钟前
Ricardo完成签到 ,获得积分10
7分钟前
长孙归尘完成签到 ,获得积分10
7分钟前
weihe完成签到,获得积分10
8分钟前
9分钟前
9分钟前
aq22完成签到 ,获得积分10
9分钟前
健康的大船完成签到 ,获得积分10
9分钟前
mili发布了新的文献求助10
9分钟前
yindi1991完成签到 ,获得积分10
10分钟前
10分钟前
zho发布了新的文献求助10
11分钟前
12分钟前
冬去春来完成签到 ,获得积分10
12分钟前
张可完成签到 ,获得积分10
13分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Technologies supporting mass customization of apparel: A pilot project 450
Mixing the elements of mass customisation 360
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
Political Ideologies Their Origins and Impact 13th Edition 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3780851
求助须知:如何正确求助?哪些是违规求助? 3326345
关于积分的说明 10226633
捐赠科研通 3041518
什么是DOI,文献DOI怎么找? 1669491
邀请新用户注册赠送积分活动 799068
科研通“疑难数据库(出版商)”最低求助积分说明 758732